ArticlePflugers Archiv : European journal of physiology2025
Protective effects of low-dose lithium treatment on rat postural muscle under conditions of disuse.
Article in Pflugers Archiv : European journal of physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Skeletal muscles undergo significant atrophy and loss of strength under conditions of disuse/mechanical unloading. Since low-dose lithium treatment has been shown to benefit the musculoskeletal system of mammals, this study sought to investigate the effects of subtherapeutic doses of lithium chloride (LiCl) on the functional properties and markers of protein metabolism in the postural soleus muscle of rats under 7 days of mechanical unloading. Rat hindlimbs were unloaded using the hindlimb suspension (HS) method. Male Wistar rats were divided into four groups: (1) vivarium control (C), (2) vivarium control + LiCl (C + Li), (3) 7-day HS (HS), and (4) 7-day HS + LiCl (HS + Li). LiCl (40 mg/kg) was administered intraperitoneally daily throughout the experiment. Structural changes in the muscle were studied using immunohistochemistry. Markers of anabolic and catabolic processes were assessed using Western blotting and PCR. LiCl treatment during HS prevented a decrease in muscle fiber size and slow-to-fast fiber transformation. Additionally, LiCl administration during HS increased the specific maximum force and passive tension of the soleus compared to the control. LiCl administration during HS prevented decreases in GSK-3β (Ser9) and 4E-BP1 (Thr37/46) phosphorylation. Furthermore, LiCl prevented the HS-induced increase in ubiquitin, atrogin-1, MuRF-1, ULK1, and calpain-1 mRNA expression. Thus, daily low-dose LiCl administration during 7-day HS maintained the morphological parameters and increased the functional properties of the rat soleus muscle. This was accompanied by the prevention of the activation of the key proteolytic markers in the soleus muscle.
Indexed as
Identifiers
41345291What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.